Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Endophenotypes of Non-Paraneoplastic Limbic Encephalitis in Childhood and Possible Underlying Immune Deficiencies/Dysregulations: A Case Series and Literature Review
Autoimmune Neurology
P11 - Poster Session 11 (8:00 AM-9:00 AM)
15-011
Our aim is to characterize features of non-paraneoplastic LE in children and correlate them with underlying immunodeficiencies. 
Limbic encephalitis (LE) is a rare disease in children but with a well-recognizable signature. Beyond the association with anti-neuronal antibodies (Ab), no dysimmune phenotype was associated with LE. Natural killer (NK) cells have disease-limiting role in neuroinflammation. 
Retrospective case series of eight patients with LE. We performed literature review from 2000-2017. Inclusion criteria included age < 18 years, symptoms of LE, absence of tumor, with either MRI, pathology or LE antibodies marker(s).   
The age range at first symptom was between 1-16 years. The clinical presentation was either acute (n=5) or insidious (n=3) encephalopathy. Symptoms included temporal epilepsy (n=6), ADHD or autistic symptoms (n=2), and memory changes (n=3). Patients had low NK cells (n=3), both VGKC and TPO Abs (n=1), TPO Ab (n=2), low lymphocytes, low B cells, and low IgA, IgG, IgM levels (n=1), low lymphocyte count (n=1), and low IgA (n=1). We had a spectrum of outcomes, from responding to anti-epileptics to more aggressive immunotherapy. Five patients improved or underwent remission after first intervention and three others are still progressing. From literature review, we included 85. Among these 10% had a progressive course or death 2%. Neurological sequelae were seen in 89%. Immune dysregulation was reported among four patients of which, two had a progressive course.     
Even if most patient with non-paraneoplastic LE has a non-progressive course, most of them suffer a neurological sequalae.  Among patients who underwent immunological workup half of them seem to have an immune dysregulation. Our findings although limited in number suggest a full immunological workup for any patient with suspected LE.
Authors/Disclosures
Abdulla Alawadhi, MBBS (Dubai health / AJCH)
PRESENTER
Dr. Alawadhi has nothing to disclose.
No disclosure on file
No disclosure on file
Guillaume Sebire (McGill University) No disclosure on file